A new Labcorp technique for early detection of Alzheimer’s disease for adults ages 50 and older has become available nationwide, the Burlington company announced last week. The Food and Drug ...

Lumipulse® pTau-217/Beta Amyloid 42 Ratio now available nationwide through Labcorp BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive ...

Labcorp Holdings, Inc. LH has announced the nationwide availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio — the first FDA-cleared blood-based in-vitro diagnostic (IVD) test to assist in ...

Labcorp has launched the first blood-based in-vitro diagnostic test cleared by the Food and Drug Administration to aid in the diagnosis of Alzheimer's disease. The test--called the Lumipulse ...

Labcorp (LH) announced the availability of the Lumipulse pTau-217/Beta Amyloid 42 Ratio, the first blood-based in-vitro diagnostic test cleared by the U.S. FDA to aid in the diagnosis of Alzheimer’s ...

Labcorp Holdings Inc. ( NYSE: LH) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:45 AM EDT ...

Qiagen N.V. ( NYSE: QGEN) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:05 PM EDT ...

Taco Bell Is 'Not Playing Around' With Its Newest Test Menu Items originally appeared on Parade. Taco Bell's latest menu update is a big one, and it may sound cheesy, but some fans are sizzlin' with ...